Global Nuclear Medicine/Radiopharmaceuticals Market Overview:
Global Nuclear Medicine/Radiopharmaceuticals Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2025 as the base year.
Global Nuclear Medicine/Radiopharmaceuticals Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Nuclear Medicine/Radiopharmaceuticals involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Nuclear Medicine/Radiopharmaceuticals Market:
The Nuclear Medicine/Radiopharmaceuticals Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Nuclear Medicine/Radiopharmaceuticals Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Nuclear Medicine/Radiopharmaceuticals Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Nuclear Medicine/Radiopharmaceuticals market has been segmented into:
Diagnostic Applications
By Application, Nuclear Medicine/Radiopharmaceuticals market has been segmented into:
Diagnostic Procedures
Therapeutic Procedures
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nuclear Medicine/Radiopharmaceuticals market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Nuclear Medicine/Radiopharmaceuticals market.
Top Key Players Covered in Nuclear Medicine/Radiopharmaceuticals market are:
Cardinal Health
Inc.
Mallinckrodt PLC
GE Healthcare (A Fully-Owned Subsidiary of General Electric Company)
Lantheus Medical Imaging
Inc.
Bayer AG
Bracco Imaging S.P.A
Eczacibasi-Monrol Nuclear Products.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Nuclear Medicine/Radiopharmaceuticals Market by Type
4.1 Nuclear Medicine/Radiopharmaceuticals Market Snapshot and Growth Engine
4.2 Nuclear Medicine/Radiopharmaceuticals Market Overview
4.3 Diagnostic Applications
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Diagnostic Applications: Geographic Segmentation Analysis
Chapter 5: Nuclear Medicine/Radiopharmaceuticals Market by Application
5.1 Nuclear Medicine/Radiopharmaceuticals Market Snapshot and Growth Engine
5.2 Nuclear Medicine/Radiopharmaceuticals Market Overview
5.3 Diagnostic Procedures
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Diagnostic Procedures: Geographic Segmentation Analysis
5.4 Therapeutic Procedures
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Therapeutic Procedures: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Nuclear Medicine/Radiopharmaceuticals Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CARDINAL HEALTH
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 INC.
6.4 MALLINCKRODT PLC
6.5 GE HEALTHCARE (A FULLY-OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
6.6 LANTHEUS MEDICAL IMAGING
6.7 INC.
6.8 BAYER AG
6.9 BRACCO IMAGING S.P.A
6.10 ECZACIBASI-MONROL NUCLEAR PRODUCTS.
Chapter 7: Global Nuclear Medicine/Radiopharmaceuticals Market By Region
7.1 Overview
7.2. North America Nuclear Medicine/Radiopharmaceuticals Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Diagnostic Applications
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Diagnostic Procedures
7.2.5.2 Therapeutic Procedures
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Nuclear Medicine/Radiopharmaceuticals Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Diagnostic Applications
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Diagnostic Procedures
7.3.5.2 Therapeutic Procedures
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Nuclear Medicine/Radiopharmaceuticals Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Diagnostic Applications
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Diagnostic Procedures
7.4.5.2 Therapeutic Procedures
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Diagnostic Applications
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Diagnostic Procedures
7.5.5.2 Therapeutic Procedures
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Diagnostic Applications
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Diagnostic Procedures
7.6.5.2 Therapeutic Procedures
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Nuclear Medicine/Radiopharmaceuticals Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Diagnostic Applications
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Diagnostic Procedures
7.7.5.2 Therapeutic Procedures
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Nuclear Medicine/Radiopharmaceuticals Scope:
|
Report Data
|
Nuclear Medicine/Radiopharmaceuticals Market
|
|
Nuclear Medicine/Radiopharmaceuticals Market Size in 2025
|
USD XX million
|
|
Nuclear Medicine/Radiopharmaceuticals CAGR 2025 - 2032
|
XX%
|
|
Nuclear Medicine/Radiopharmaceuticals Base Year
|
2024
|
|
Nuclear Medicine/Radiopharmaceuticals Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Cardinal Health, Inc., Mallinckrodt PLC, GE Healthcare (A Fully-Owned Subsidiary of General Electric Company), Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products..
|
|
Key Segments
|
By Type
Diagnostic Applications
By Applications
Diagnostic Procedures
Therapeutic Procedures
|
